Cancer vaccines entering Phase III clinical trials

By Durrant LG   Spendlove I  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials

By Stallard Nigel  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 787-801

Taylor & Francis Ltd

Access to resources Recommend Favorite

Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?

By  

Current Gene Therapy, Vol. 9, Iss. 5, 2009-01 ,pp. : 368-374

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Launch Clinical Investigator Drug Prescribing in the US: The Behaviour of Clinical Trial Investigators after Participating in Phase III Trials

By Glass Harold E.   Rosenthal Bruce  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 2, 2005-01 ,pp. : 97-104

Adis International

Access to resources Recommend Favorite

An Urn Model for Odds-Ratio-Based Response-Adaptive Phase III Clinical Trials for Two or More Treatments

By Basak Gopal  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 5, 2009-09 ,pp. : 838-856

Taylor & Francis Ltd

Access to resources Recommend Favorite